文章基本信息

标题：Polymorphisms in the gene encoding lipoprotein lipase in men with low HDL-C and coronary heart disease The Veterans Affairs HDL Intervention Trial
本地全文：下载
作者：Margaret E. Brousseau ; Allison L. Goldkamp ; Dorothea Collins 等
期刊名称：JLR Papers In Press
印刷版ISSN：0022-2275
电子版ISSN：1539-7262
出版年度：2004
卷号：45
期号：10
页码：1885-1891
DOI：10.1194/jlr.M400152-JLR200
语种：English
出版社：American Society for Biochemistry and Molecular Biology
摘要：Our goal was to further define the role of LPL gene polymorphisms in coronary heart disease (CHD) risk. We determined the frequencies of three LPL polymorphisms (D9N, N291S, and S447X) in 899 men from the Veterans Affairs HDL Intervention Trial (VA-HIT), a study that examined the potential benefits of increasing HDL with gemfibrozil in men with established CHD and low high density lipoprotein cholesterol (HDL-C; ⩽40 mg/dl), and compared them with those of men without CHD from the Framingham Offspring Study (FOS). In VA-HIT, genotype frequencies for LPL D9N, N291S, and S447X were 5.3, 4.5, and 13.0%, respectively. These values differed from those for men in FOS having an HDL-C of >40, who had corresponding values of 3.2% ( P = 0.06), 1.5% ( P P LPL N9 allele in VA-HIT had lower levels of large LDL (−32%; P P LPL N9 carriers than in noncarriers (20.14 ± 0.87 vs. 20.63 ± 0.80 nm; P In men with low HDL-C and CHD: 1 ) the LPL N9 and S291 alleles are more frequent than in CHD-free men with normal HDL-C, whereas the X447 allele is less frequent, and 2 ) the LPL N9 allele is associated with the LDL subclass response to gemfibrozil.